4:36 PM ET
8-K
Loan & Debt
Usana Health Sciences $75M Debt Financing with Bank of America, N.A.
USANA Health Sciences entered into a first amendment to its $75 million revolving credit facility with Bank of America. The amendment modifies financial covenants, including a minimum consolidated EBITDA requirement of $100 million, and increases the annual limit for general asset disposals to $2.5 million. It also specifically permits the sale and potential leaseback of the company's real property in Sydney, Australia.
- Value
- $75M
- Counterparty
- Bank of America, N.A.
- Term
- through June 2030